scholarly article | Q13442814 |
P356 | DOI | 10.1002/JCB.24665 |
P698 | PubMed publication ID | 24038379 |
P2093 | author name string | Yan Li | |
Weina Li | |||
Shouzhen Wu | |||
Liqiang Song | |||
Zhikui Li | |||
P2860 | cites work | Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. | Q36923079 |
Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma | Q39432618 | ||
MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. | Q39433284 | ||
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. | Q39459142 | ||
miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. | Q39604058 | ||
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells | Q39690486 | ||
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis | Q43108292 | ||
miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. | Q45878289 | ||
The functions of animal microRNAs | Q27860621 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila | Q28131827 | ||
Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance | Q28267606 | ||
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells | Q28278471 | ||
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines | Q28975767 | ||
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN | Q29616575 | ||
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. | Q33345021 | ||
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells | Q33895297 | ||
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin | Q34094556 | ||
A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance | Q34110688 | ||
miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. | Q34160439 | ||
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. | Q34798833 | ||
miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans | Q35187051 | ||
Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). | Q35812082 | ||
Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice? | Q36315282 | ||
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia | Q36437006 | ||
miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo | Q36610611 | ||
The roles of copper transporters in cisplatin resistance | Q36743623 | ||
P433 | issue | 7 | |
P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
P304 | page(s) | 1234-1242 | |
P577 | publication date | 2014-07-01 | |
P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
P1476 | title | miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A). | |
P478 | volume | 115 |
Q41439806 | A Role for The ATP7A Copper Transporter in Tumorigenesis and Cisplatin Resistance |
Q38390451 | A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma. |
Q36193907 | Downregulated miR-495 [Corrected] Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer |
Q57024561 | Effect of microRNA-495 on lower extremity deep vein thrombosis through the TLR4 signaling pathway by regulation of IL1R1 |
Q26996766 | Epigenetics of lung cancer |
Q33598360 | Expression, regulation and function of miR-495 in healthy and tumor tissues |
Q64279220 | Genetic associations between the miRNA polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and miR-495 (rs2281611) and colorectal cancer susceptibility |
Q36790395 | MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin |
Q49449309 | MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1. |
Q49409530 | MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas. |
Q38262308 | Molecular functions and significance of the MTA family in hormone-independent cancer |
Q38343461 | Natural product modulators to overcome multidrug resistance in cancer. |
Q26863490 | Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer |
Q37366231 | Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer |
Q60907638 | TAp73 regulates ATP7A: possible implications for ageing-related diseases |
Q91710491 | The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents |
Q55365074 | miR-495 inhibits proliferation, migration, and invasion and induces apoptosis via inhibiting PBX3 in melanoma cells. |
Q38633144 | miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance |
Q38667020 | microRNA and Lung Cancer. |
Q26778918 | microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment |
Search more.